RecruitingNCT07214207
Suvorexant for alcohol use and stress-related drinking
About this title
Read the official source — NCT07214207Medication studyAges 18–65United StatesAddiction
Understand this study
Who could participate?
Listed age limits: 18 years to 65 years.
What will I do during this study?
Participants take suvorexant or placebo (an inactive comparison treatment) by mouth each night for eight weeks and record medication use, side effects, sleep, alcohol use and mood in a smartphone diary each day. They attend laboratory visits at the start, week 4 and week 8, including a stress-response test with physiological measurements.
- Listed locations
- ColumbusSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Participation duration
- 8 weeks
- Number of visits
- 3 laboratory visits
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: December 4, 2025
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 250
- Sponsor
- Ohio State University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug, Other
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT07214207
- Official title
Show the full official title
Orexin Receptor Antagonism for the Treatment of Alcohol Use Disorder and Stress-Related Drinking
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Columbus
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Ohio State University, a university.
Does this study involve medication?
Yes. The study involves medication, including Suvorexant 10 mg.
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as recruiting.
